Shenyang Aojina Pharmaceutical

Shenyang Aojina Pharmaceutical is a prominent Chinese pharmaceutical company focused on the research, development, and production of cardiovascular and cerebrovascular drugs. Founded in 1991, the company has built a strong reputation for its high-quality aspirin enteric-coated tablets, which are widely used for the prevention of ischemic heart disease and stroke. Aojina operates advanced manufacturing facilities that comply with national GMP standards and maintains a significant market share in China's cardiovascular drug sector. In addition to its flagship aspirin products, the company develops pediatric medications and other essential therapies. Aojina is recognized for its commitment to quality control and its role in providing affordable, effective treatments for chronic conditions. The company's research efforts continue to focus on optimizing drug delivery and expanding its portfolio within the cardiovascular space.